BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20639750)

  • 1. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis.
    Kumar A; Zarychanski R; Light B; Parrillo J; Maki D; Simon D; Laporta D; Lapinsky S; Ellis P; Mirzanejad Y; Martinka G; Keenan S; Wood G; Arabi Y; Feinstein D; Kumar A; Dodek P; Kravetsky L; Doucette S;
    Crit Care Med; 2010 Sep; 38(9):1773-85. PubMed ID: 20639750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis.
    Jacobs FM
    Crit Care Med; 2011 Mar; 39(3):608; author reply 609. PubMed ID: 21330874
    [No Abstract]   [Full Text] [Related]  

  • 3. A potential selection bias in the study of early combination antibiotic therapy versus monotherapy in septic shock.
    Kim DH
    Crit Care Med; 2011 Jun; 39(6):1604; author reply 1604-5. PubMed ID: 21610652
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
    Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
    Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.
    Rodríguez A; Mendia A; Sirvent JM; Barcenilla F; de la Torre-Prados MV; Solé-Violán J; Rello J;
    Crit Care Med; 2007 Jun; 35(6):1493-8. PubMed ID: 17452932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination versus monotherapy for septic shock patients.
    Shaw PA
    Crit Care Med; 2010 Sep; 38(9):1905-6. PubMed ID: 20724887
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
    Blot S; Depuydt P
    Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
    [No Abstract]   [Full Text] [Related]  

  • 9. Mono- or combination antibiotic therapy for septic shock? An epistemological dilemma.
    Corona A
    Crit Care Med; 2011 Feb; 39(2):423-4; author reply 424-5. PubMed ID: 21248539
    [No Abstract]   [Full Text] [Related]  

  • 10. Septic shock in digestive surgery: a retrospective study of 89 patients.
    Hizette P; Simoens C; Massaut J; Thill V; Smets D; da Costa PM
    Hepatogastroenterology; 2009; 56(96):1615-21. PubMed ID: 20214204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
    Raurich JM; Llompart-Pou JA; Ibáñez J; Frontera G; Pérez O; García L; Ayestarán JI
    J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy in patients with septic shock.
    Textoris J; Wiramus S; Martin C; Leone M
    Eur J Anaesthesiol; 2011 May; 28(5):318-24. PubMed ID: 21464717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.
    Patel GP; Simon D; Scheetz M; Crank CW; Lodise T; Patel N
    Am J Ther; 2009; 16(6):508-11. PubMed ID: 19531934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
    Kumar A; Safdar N; Kethireddy S; Chateau D
    Crit Care Med; 2010 Aug; 38(8):1651-64. PubMed ID: 20562695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis and septic shock: selection of empiric antimicrobial therapy.
    Cunha BA
    Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI; Beilman GJ; Chipman JG; Mann HJ
    Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for septic shock: considerations for antibiotic stewardship.
    Mehta SA; Phillips MS
    Crit Care Med; 2011 Mar; 39(3):608-9; author reply 609. PubMed ID: 21330873
    [No Abstract]   [Full Text] [Related]  

  • 19. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.
    Swoboda S; Ober M; Hainer C; Lichtenstern C; Seiler C; Wendt C; Hoppe-Tichy T; Büchler M; Weigand MA
    J Antimicrob Chemother; 2008 Mar; 61(3):729-33. PubMed ID: 18222953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one?
    Abad CL; Kumar A; Safdar N
    Crit Care Clin; 2011 Apr; 27(2):e1-27. PubMed ID: 21440195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.